NTLA
Intellia Therapeutics, Inc. · Healthcare
Director Frank Verwiel sold $38K of Intellia Therapeutics, Inc.
Sold$37,625
$25.00Price
1,505Shares
−8%Stake
What NTLA did after the filing
- The stock from Thu, Jun 20 close, $24.15
- −1.2%
- S&P 500, same days
- −2.3%
Measured over 30 trading days, to the Aug 2 close.
Traded Mon, Jun 17. Filed Thu, Jun 20, 1:00 PM ET, during the session. Returns use the Jun 20 close and the Aug 2 close. Not investment advice.